Glycine-induced long-term synaptic potentiation is mediated by the glycine transporter GLYT1

Neuropharmacology

Volumn 52, Issue 8, 2007, Pages 1586-1595

  Igartua, Itziar ^a   Solís, José M ^a   Bustamante, Julián ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

d serine; Glycine; Glycine transporters; Hippocampus; LTP; NMDA receptors; Rat

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; [[3 (4 FLUOROPHENYL) 3 (4 PHENYLPHENOXY)PROPYL]]SARCOSINE; ALX 5407; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; DIZOCILPINE; GLYCINE; GLYCINE RECEPTOR; GLYCINE TRANSPORTER 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NIFEDIPINE; SARCOSINE; STRYCHNINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NONHUMAN; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RAT; RECEPTOR BLOCKING; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GLYCINE; GLYCINE AGENTS; GLYCINE PLASMA MEMBRANE TRANSPORT PROTEINS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; SARCOSINE; STRYCHNINE; SYNAPSES;

EID: 34249701259     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.03.003     Document Type: Article

References (58)

1. Abel T., Nguyen P.V., Barad M., Deuel T.A.S., Kandel E.R., and Bourtchouladze R. Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell 88 (1997) 615-626
2. Aragón C., and López-Corcuera B. Structure, function and regulation of glycine neurotransporters. European Journal of Pharmacology 479 (2003) 249-262
3. Atkinson B.N., Bell S.C., De Vivo M., Kowalski L.R., Lechner S.M., Ognyanov V.I., Tham C.S., Tsai C., Jia J., Ashton D., and Klitenick M.A. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Molecular Pharmacology 60 (2001) 1414-1420
4. Barth A., Nguyen L.B., Barth L., and Newell D.W. Glycine-induced neurotoxicity in organotypic hippocampal slice cultures. Experimental Brain Research 161 (2005) 351-357
5. Berger A.J., Dieudonne S., and Ascher P. Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. Journal of Neurophysiology 80 (1998) 3336-3340
6. Bergeron R., Meyer T.M., Coyle J.T., and Greene R.W. Modulation of N-methyl-d-aspartate receptor function by glycine transport. Proceedings of the National Academy of Sciences USA 95 (1998) 15730-15734
7. Billups D., and Attwell D. Active release of glycine or d-serine saturates the glycine site of NMDA receptors at the cerebellar mossy fibre to granule cell synapse. European Journal of Neuroscience 18 (2003) 2975-2980
8. Bliss T.V.P., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
9. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Cul J., Tu S., Sevarino K.A., Nakanishi N., Tong G., Lipton S.A., and Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature 415 (2002) 793-798
10. Chattipakorn S.C., and McMahon L.L. Pharmacological characterization of glycine-gated chloride currents recorded in rat hippocampal slices. Journal of Neurophysiology 87 (2002) 1515-1525
11. Chen L., Muhlhauser M., and Yang C.R. Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. Journal of Neurophysiology 89 (2003) 691-703
12. Cubelos B., Gimenez C., and Zafra F. Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cerebral Cortex 15 (2005) 448-459
13. del Olmo N., Galarreta M., Bustamante J., Martín del Río R., and Solís J.M. Taurine-induced synaptic potentiation: role of calcium and interaction with LTP. Neuropharmacology 39 (2000) 40-54
14. del Olmo N., Handler A., Alvarez L., Bustamante J., Martín del Río R., and Solís J.M. Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically. Neuropharmacology 44 (2003) 26-39
15. del Olmo N., Suárez L.M., Orensanz L.M., Suárez F., Bustamante J., Duarte J.M., Martín del Río R., and Solís J.M. Role of taurine uptake on the induction of long-term potentiation. European Journal of Neuroscience 19 (2004) 1875-1886
16. Etoh S., Baba A., and Iwata H. NMDA induces protein kinase C translocation in hippocampal slices of immature rat brain. Neuroscience Letters 126 (1991) 119-122
17. Galarreta M., Bustamante J., Martín del Río R., and Solís J.M. Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. The Journal of Neuroscience 16 (1996) 92-102
18. Gomeza J., Zafra F., Olivares L., Gimenez C., and Aragon C. Regulation by phorbol esters of the glycine transporter (GLYT1) in glioblastoma cells. Biochimica and Biophysica Acta 1233 (1995) 41-46
19. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology 174 (2004) 151-162
20. Herdon H.J., Godgrey F.M., Brown A.M., Coulton S., Evans J.R., and Cairns W.J. Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes. Neuropharmacology 41 (2001) 88-96
21. Heresco-Levy U., Javitt D.C., Ermilov M., Mordel C., Silipo G., and Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Archives of General Psychiatry 56 (1999) 29-36
22. Javitt D.C. Is the glycine site half saturated? Effects of glutamatergic drugs in schizophrenia patients. Current Opinion on Psychiatry 19 (2006) 151-157
23. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. The American Journal of Psychiatry 148 (1991) 1301-1308
24. Javitt D.C., Sershen H., Hashim A., and Lajtha A. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide. Neuropsychopharmacology 17 (1997) 202-204
25. Johnson J.W., and Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325 (1987) 529-531
26. Kew J.N., Koester A., Moreau J.L., Jenck F., Ouagazzal A.M., Mutel V., Richards J.G., Trube G., Fischer G., Montkowski A., Hundt W., Reinscheid R.K., Pauly-Evers M., Kemp J.A., and Bluethmann H. Functional consequences of reduction in NMDA receptor glycine affinity in mice carrying targeted point mutations in the glycine binding site. Journal of Neuroscience 20 (2000) 4037-4049
27. Lane H.Y., Chang Y.C., Liu Y.C., Chiu C.C., and Tsai G.E. Sarcosine or d-serine add-on treatment for acute exarcerbation of schizophrenia: a randomized, doubled-blind, placebo-controlled study. Archives of General Psychiatry 62 (2005) 1196-11204
28. Lee H.-K., Kameyama K., Huganir R.L., and Bear M.F. NMDA induces long-term synaptic depression and dephosphorylation of the GluR1 subunit of AMPA receptors in hippocampus. Neuron 21 (1998) 1151-1162
29. Lipina T., Labrie V., Weiner I., and Roder J. Modulators of the glycine site on NMDA receptors, d-serine and ALX5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology 179 (2005) 54-67
30. López-Corcuera B., Vazquez J., and Aragón C. Purification of the sodium- and chloride-coupled glycine transporter from central nervous system. Journal of Biological Chemistry 266 (1991) 24809-24814
31. Malenka R.C., and Nicoll R.A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends in Neurosciences 16 (1993) 521-527
32. Manabe T., Wyllie D.J.A., Perkel D.J., and Nicoll R.A. Modulation of synaptic transmission and long-term potentiation: effects of paired-pulse facilitation and EPSC variance in the CA1 region of the hippocampus. Journal of Neurophysiology 70 (1993) 1451-1459
33. Martin S.J., and Morris R.G. New life in an old idea: the synaptic plasticity and memory hypothesis revisited. Hippocampus 12 (2002) 609-636
34. Matsui T., Sekiguchi M., Hashimoto A., Tomita U., Nishikawa T., and Wada K. Functional comparison of d-serine and glycine in rodents: the effect on cloned NMDA receptors and the extracellular concentration. Journal of Neurochemistry 1995 65 (1995) 454-458
35. Millan M.J. N-methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology 179 (2005) 30-53
36. Mothet J.P., Parent A.T., Wolosker H., Brady Jr. R.O., Linden D.J., Ferris C.D., Rogawski M.A., and Snyder S.H. d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proceedings of National Academy of Sciences USA 97 (2000) 4926-4931
37. Musleh W., Bi X., Tocco G., Yaghoubi S., and Baudry M. Glycine-induced long-term potentiation is associated with structural and functional modifications of alpha-amino-3-hydroxyl-5-methyl-4-isoxazolepropionic acid receptors. Proceedings of National Academy of Sciences USA 94 (1997) 9451-9456
38. Newell D.W., Barth A., Ricciardi T.N., and Malouf A.T. Glycine causes increased excitability and neurotoxicity by activation of NMDA receptors in the hippocampus. Experimental Neurology 145 (1997) 235-244
39. Olney J.W., Newcomer J.W., and Farber N.B. NMDA receptor hypofunction model of schizophrenia. Journal of Psychiatric Research 33 (1999) 523-533
40. Platt B., Bate J.R., von Linstow Roloff E., and Withington D.J. Glycine induces a novel form of long-term potentiation in the superficial layers of the superior colliculus. British Journal of Pharmacology 125 (1998) 293-300
41. Raiteri L., Stigliani S., Siri A., Passalacqua M., Melloni E., Raiteri M., and Bonanno G. Glycine taken up through GLYT1 and GLYT2 heterotransporters into glutamatergic axon terminals of mouse spinal cord elicits release of glutamate by homotransporter reversal and through anion channels. Biochemical Pharmacology 69 (2005) 159-168
42. + signals in spines and dendrites. The Journal of Neurosciences 21 (2001) 4207-4214
43. Sato K., Adams R., Betz H., and Schloss P. Modulation of a recombinant glycine transporter (GLYT1b) by activation of protein kinase C. Journal of Neurochemistry 65 (1995) 1967-1973
44. Schulte M.K., Roon R.J., Chalmers D.J., Sunter D.C., and Koerner J.F. Utilization of the resolved l-isomer of 2-amino-6-phosphonohexanoic acid (L-AP-6) as a selective agonist for a quisqualate-sensitized site in hippocampal CA1 pyramidal neurons. Brain Research 649 (1994) 203-207
45. Sergeeva O.A., Chepkova A.N., Doreulee N., Eriksson K.S., Poelchen W., Mönnighoff I., Heller-Stilb B., Warskulat U., Häussinger D., and Haas H.L. Taurine-induced long-lasting enhancement of synaptic transmission in mice: role of transporters. Journal of Physiology 550 (2003) 911-919
46. Shahi K., and Baudry M. Glycine-induced changes in synaptic efficacy in hippocampal slices involve changes in AMPA receptors. Brain Research 627 (1993) 261-266
47. Shahi K., Marvizon J.C., and Baudry M. High concentrations of glycine induce long-lasting changes in synaptic efficacy in rat hippocampal slices. Neuroscience Letters 149 (1993) 185-188
48. Smith K.E., Borden L.A., Hartig P.R., Branchek T., and Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 8 (1992) 927-935
49. Song W., Chattipakorn S.C., and McMahon L.L. Glycine-gated chloride channels depress synaptic transmission in rat hippocampus. Journal of Neurophysiology 95 (2006) 2366-2379
50. Suárez L.M., and Solís J.M. Taurine potentiates presynaptic NMDA receptors in hippocampal Schaffer collateral axons. European Journal of Neuroscience 24 (2006) 405-418
51. Supplisson S., and Bergman C. Control of NMDA receptor activation by a glycine transporter co-expressed in Xenopus Oocytes. The Journal of Neuroscience 17 (1997) 4580-4590
52. Thomson A.M., Walker V.E., and Flynn D.M. Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature 338 (1989) 422-424
53. Tsai G., and Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annual Review of Pharmacology and Toxicology 42 (2002) 165-179
54. Tsai G., Lane H.Y., Yang P., Chong M.Y., and Lange N. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biological Psychiatry 55 (2004) 452-456
55. Vaccarino F.M., Liljequist S., and Tallman J.F. Modulation of protein kinase C translocation by excitatory and inhibitory amino acids in primary cultures of neurons. Journal of Neurochemistry 57 (1991) 191-396
56. Wallis R.A., Panizzon K.L., and Nolan J.P. Glycine-induced CA1 excitotoxicity in the rat hippocampal slice. Brain Research 664 (1994) 115-125
57. Watanabe Y., Saito H., and Abe K. Effects of glycine and structurally related amino acids on generation of long-term potentiation in rat hippocampal slices. European Journal of Pharmacology 223 (1992) 179-184
58. Waxman E.A., and Lynch D.R. N-methyl-d-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 11 (2005) 37-49